The benefits of implementing interprofessional and teambased programs are well recognized. However, for interprofessional education to be effective and broadly implemented, the health professions, policymakers, insurers, academic institutions, health care providers, and regulatory bodies should embrace and adopt a new, interprofessional education framework. These stakeholders should create a shared value and vision for interprofessional health professions education, research, and practice. This vision should be patientoriented and contain a measurable component across the entire educational continuum, from admission into a health professional program through retirement. Such a framework would maximize and value the strengths of individual professions in the integrated delivery of high quality care. Finally, in creating a successful model, a series of questions should be considered: how best can team competence be measured, how should individual behavioral changes be documented when we think of individual rather than teamlevel changes, how do we create and measure performance criteria based on shared understanding and experience in the practice setting? Within academic settings, there are more specific barriers including a lack of administrative support, financial and human resources for interprofessional education, conflicts in schedules and health professions curricula, and limitations to the time required to plan and implement faculty development for interprofessional learning. Finally, despite progress, there remain regulatory and professional barriers to achieving full and meaningful implementation of effective models. Recommendations which are given emphasize that investing in research to evaluate the efficacy of continuing education and its impact on patient outcomes and the healthcare delivery system is inherent in this process., Biljana Gjorgjeska, and Literatura
Tumory centrálního nervového systému (CNS) tvoří 20-25% všech nádorových onemocnění u dětí do 15 let věku, jsou hlavní příčinou úmrtí onkologických dětských pacientů (1). Asi 30% nádorů se vyskytuje do 5 let věku, 70-75 % se vyskytuje do 10 let věku. Nádory CNS jsou lokalizované převážně (60%) v zadní jámě: medulloblastom, low-grade astrocytom, ependymom. Práce je zaměřena na problematiku intraventrikulárních tumorů., Central nervous system tumors (CNS) account 20-25% of all malignancies in children under 15 years of age. They are the main cause of death in pediatrie oncology patients (1). Approximately 30% of CNS tumors occur under 5 years of age, 70-75% are found under 10 years of age. 60% are found in posterior fossa: medulloblastoma, low-grade astrocytoma, ependymoma. The article is directed to intraventricular tumors in children., Jarmila Skotáková, Marcela Charvátová, Vlastirad Mach, Jan Šenkyřík, JiříVentruba, Zdeněk Mackerle, Zdeněk Pavelka, Karel Zitterbart, and Literatura 16
Invazívne mykotické infekcie predstavujú závažnú infekčnú komplikáciu imunokompromitovaných pacientov. V porovnaní s bakteriálnymi infekciami je ich výskyt menej častý, na druhú stranu mortalita s nimi spojená je výrazne vyššia než je tomu u infekcií bakteriálnych. Posledné dve desaťročia priniesli významné zmeny v epidemiológii invazívnych mykóz a behom posledných niekoľkých rokov došlo k značným pokrokom v diagnostike a liečbe., Invasive fungal infections are serious life-threatening complication in immunocompromised patients. They are rare in comparison with bacterial infection but attributable mortality is higher. Last two decades brought significant changes in epidemiology of invasive fungal diseases and the last few years brought much progress in diagnostics and treatment., Martina Tošková, Jana Winterová, Iva Kocmanová, Zdeněk Ráčil, and Literatura